lomustine has been researched along with Mastocytosis in 2 studies
Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vincenti, S | 1 |
| Findji, F | 1 |
| Rassnick, KM | 1 |
| Bailey, DB | 1 |
| Russell, DS | 1 |
| Flory, AB | 1 |
| Kiselow, MA | 1 |
| Intile, JL | 1 |
| Malone, EK | 1 |
| Balkman, CE | 1 |
| Barnard, SM | 1 |
1 trial available for lomustine and Mastocytosis
| Article | Year |
|---|---|
A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, | 2010 |
1 other study available for lomustine and Mastocytosis
| Article | Year |
|---|---|
Influence of treatment on the outcome of dogs with incompletely excised grade-2 mast cell tumors.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dog Diseases; Dogs; Follow-Up Studies; Lo | 2017 |